01820nas a2200289   4500000000100000008004100001260001300042653001500055653001000070653001100080653001100091653003000102653001200132653002600144653000900170653001600179653001100195653001800206100001200224700001800236245012300254856009000377300001200467490000700479520103000486022001401516       1976                            d  c1976 Dec10aAdolescent10aAdult10aFemale10aHumans10aHypersensitivity, Delayed10aleprosy10aLymphocyte Activation10aMale10aMiddle Aged10aPlasma10aT-Lymphocytes1 aBjune G1 aBarnetson R S00aPlasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions.  uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540990/pdf/clinexpimmunol00244-0025.pdf  a397-4020 v263 a<p>The phytohaemagglutinin-induced responses of lymphocytes were found to be inhibited by plasma from patients with leprosy when compared with their responses in pooled serum from healthy donors. When patients developed reversal reactions, the initial inhibitory effect of their plasma was replaced by an augmentary effect on the responses to phytohaemagglutinin. The period of augmentation coincided with that of the reversal reaction in patients with borderline tuberculoid leprosy, but was delayed in patients with borderline lepromatous leprosy. The plasma from each leprosy patient was also observed to have the same effect on lymphocytes from unrelated individuals, showing that the inhibition and augmentation were due to factors in the plasma and not to a change in lymphocyte receptors. It is possible that the normal stable state of leprosy results from the presence of factors in plasma which act as a control mechanism, and that delayed hypersensitivity reactions may be caused by a breakdown of this control.</p>  a0009-9104